Subjective health expectations at biological therapy initiation: A survey of rheumatoid arthritis patients and rheumatologists

European Journal of Health Economics

Volumn 15, Issue SUPPL. 1, 2014, Pages

  Péntek, Márta ^a,b   Gulácsi, László ^a   Rojkovich, Bernadette ^c   Brodszky, Valentin ^a   Van Exel, Job ^d   Brouwer, Werner B F ^d  

^a Institute of Data Analytics and Information Systems   (Hungary)

^b Pest Megyei Flor Ferenc Korhaz   (Hungary)

^c Department of Rheumatology II Polyclinic of the Hospital Brothers of St John of God in Budapest ^*  (Hungary)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Arthritis, rheumatoid; Biological drugs; EQ 5D; Health expectations; Hungary

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; ANTIRHEUMATIC AGENT; BIOLOGICAL FACTOR;

ADULT; ARTICLE; BIOLOGICAL THERAPY; CROSS-SECTIONAL STUDY; DAS28; DISEASE ACTIVITY; DISEASE DURATION; EDUCATIONAL STATUS; EMPLOYMENT STATUS; EXPECTATION; FEMALE; FUNCTIONAL DISEASE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SHORT COURSE THERAPY; ANTICIPATION; ARTHRITIS, RHEUMATOID; ATTITUDE TO HEALTH; HEALTH PERSONNEL ATTITUDE; MIDDLE AGED; PHYSICIAN; PSYCHOLOGY; QUESTIONNAIRE;

ADULT; ANTICIPATION, PSYCHOLOGICAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; BIOLOGICAL FACTORS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PHYSICIANS; QUESTIONNAIRES; RHEUMATOLOGY;

EID: 84905708224     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-014-0597-1     Document Type: Article

References (30)

1. Boonen, A., Severens, J.L.: The burden of illness of rheumatoid arthritis. Clin. Rheumatol. 30(Suppl 1), S3-S8 (2011)
2. Furneri, G., Mantovani, L.G., Belisari, A., Mosca, M., Cristiani, M., Bellelli, S., Cortesi, P.A., Turchetti, G.: Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis. Clin. Exp. Rheumatol. 30(4 Suppl 73), S72-S84 (2012)
3. Upchurch, K.S., Kay, J.: Evolution of treatment for rheumatoid arthritis. Rheumatology (Oxford) 51(Suppl 6), vi28-vi36 (2012)
4. Smolen, J.S., Landewe, R., Breedveld, F.C., Buch, M., Burmester, G., Dougados, M., Emery, P., Gaujoux-Viala, C., Gossec, L., Nam, J., Ramiro, S., Winthrop, K., de Wit, M., Aletaha, D., Betteridge, N., Bijlsma, J.W., Boers, M., Buttgereit, F., Combe, B., Cutolo, M., Damjanov, N., Hazes, J.M., Kouloumas, M., Kvien, T.K., Mariette, X., Pavelka, K., van Riel, P.L., Rubbert-Roth, A., Scholte-Voshaar, M., Scott, D.L., Sokka-Isler, T., Wong, J.B., van der Heijde, D.: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann. Rheum. Dis. 73(3), 492-509 (2014)
5. Kobelt, G., Jonsson, B.: The burden of rheumatoid arthritis and access to treatment: outcome and cost-utility of treatments. Eur J Health Econ 8(Suppl 2), 95-106 (2008)
6. Bendtsen, P., Akerlind, I., Hornquist, J.O.: Pharmacological intervention in older patients with rheumatoid arthritis. Quality of life aspects. Drugs Aging 7(5), 338-346 (1995)
7. Epstein, W.V.: Expectation bias in rheumatoid arthritis clinical trials. The anti-CD4 monoclonal antibody experience. Arthritis Rheum. 39 (11), 1773-1780 (1996)
8. Kvien, T.K., Heiberg, T.: Patient perspective in outcome assessments-perceptions or something more? J. Rheumatol. 30(4), 873-876 (2003)
9. Simon, L.S.: The treatment of rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol. 18(4), 507-538 (2004)
10. Alcorn, N., Waite, L., Madhok, R.: Transforming the expectations of patients with rheumatoid arthritis? Rheumatology (Oxford) 49(7), 1211-1212 (2010)
11. van Vollenhoven, R.F.: Unresolved issues in biologic therapy for rheumatoid arthritis. Nat. Rev. Rheumatol. 7(4), 205-215 (2011)
12. Mirowsky, J.: Subjective life expectancy in the US: correspondence to actuarial estimates by age, sex and race. Soc. Sci. Med. 49(7), 967-979 (1999)
13. Brouwer, W.B., van Exel, N.J.: Expectations regarding length and health related quality of life: some empirical findings. Soc. Sci. Med. 61(5), 1083-1094 (2005)
14. Pentek, M., Brodszky, V., Gulacsi, A.L., Hajdu, O., van Exel, J., Brouwer, W., Gulacsi, L.: Subjective expectations regarding length and health-related quality of life in Hungary: results from an empirical investigation. Health Expect. (2012). doi:10.1111/j.1369-7625.2012.00797.x
15. Marshall, N.J., Wilson, G., Lapworth, K., Kay, L.J.: Patients' perceptions of treatment with anti-TNF therapy for rheumatoid arthritis: a qualitative study. Rheumatology (Oxford) 43(8), 1034-1038 (2004)
16. Funahashi, K., Matsubara, T.: What RA patients expect of their treatment-discussion over the result of our survey. Clin. Rheumatol. 31(11), 1559-1566 (2012)
17. Bergsten, U., Bergman, S., Fridlund, B., Arvidsson, B.: Delivering knowledge and advice: healthcare providers' experiences of their interaction with patients' management of rheumatoid arthritis. Int. J. Qual. Stud. Health Well-being 6(4) (2011)
18. Buitinga, L., Braakman-Jansen, L.M., Taal, E., van de Laar, M.A.: Future expectations and worst-case future scenarios of patients with rheumatoid arthritis: a focus group study. Musculoskelet. Care 10(4), 240-247 (2012)
19. Bruce, B., Fries, J.F.: The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual. Life Outcomes 1, 20 (2003)
20. EuroQoL-Group: EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 16(3), 199-208 (1990)
21. Szende, A., Nemeth, R.: Health-related quality of life of the Hungarian population. Orv. Hetil. 144(34), 1667-1674 (2003)
22. Lillegraven, S., Kvien, T.K.: Measuring disability and quality of life in established rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol. 21(5), 827-840 (2007)
23. Anderson, J., Caplan, L., Yazdany, J., Robbins, M.L., Neogi, T., Michaud, K., Saag, K.G., O'Dell, J.R., Kazi, S.: Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis. Care Res. (Hoboken) 64 (5), 640-647 (2012)
24. Hobbs, K.F., Cohen, M.D.: Rheumatoid arthritis disease measurement: a new old idea. Rheumatology (Oxford) 51(Suppl 6), vi21-vi27 (2012)
25. Marra, C.A., Woolcott, J.C., Kopec, J.A., Shojania, K., Offer, R., Brazier, J.E., Esdaile, J.M., Anis, A.H.: A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc. Sci. Med. 60 (7), 1571-1582 (2005)
26. Schmitz, S., Adams, R., Walsh, C.D., Barry, M., FitzGerald, O.: A mixed treatment comparison of the efficacy of anti-TNF agents in rheumatoid arthritis for methotrexate non-responders demonstrates differences between treatments: a Bayesian approach. Ann. Rheum. Dis. 71(2), 225-230 (2012)
27. Ferrari, R., Russell, A.S.: Correlations between coping styles and symptom expectation for rheumatoid arthritis. Clin. Rheumatol. 29(12), 1445-1448 (2010)
28. Hofmann, D., Ibrahim, F., Rose, D., Scott, D.L., Cope, A., Wykes, T., Lempp, H.: Expectations of new treatment in rheumatoid arthritis: developing a patient-generated questionnaire. Health Expect. (2013). doi:10.1111/hex.12073
29. Yoshida, K., Radner, H., Kavanaugh, A., Sung, Y.K., Bae, S.C., Kishimoto, M., Matsui, K., Okada, M., Tohma, S., Weinblatt, M.E., Solomon, D.H.: Use of data from multiple registries in studying biologic discontinuation: challenges and opportunities. Clin. Exp. Rheumatol. 31(4 Suppl 78), S28-S32 (2013)
30. Listing, J., Kekow, J., Manger, B., Burmester, G.R., Pattloch, D., Zink, A., Strangfeld, A.: Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNF-alpha inhibitors and rituximab. Ann. Rheum. Dis. (2013). doi:10.1136/annrheumdis-2013-204021